Inter-B-NHL Ritux 2010 - Version 1.0

• Research type

  Research Study

• Full title

  Intergroup Trial for Children or Adolescents with B-cell NHL or B-AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients.

• IRAS ID

  89944

• Contact name

  Amos Burke

• Contact email

  amos.burke@addenbrookes.nhs.uk

• Sponsor organisation

  Institut Gustave Roussy

• Eudract number

  2010-019224-31

• Clinicaltrials.gov Identifier

  NCT01516580

• REC name

  East of England - Cambridge South Research Ethics Committee

• REC reference

  13/EE/0202

• Date of REC Opinion

  4 Oct 2013

• REC opinion

  Further Information Favourable Opinion